NEXT: EVERIC® PURE – THE SAFE OPTION RIGHT FROM THE START
WRONG CONTAINER CHOICE – A THREAT TO
PATIENT SAFETY AND TIME-TO-MARKET
A common situation is that pharma companies select
a certain primary packaging container and in first short
term studies, everything is fine … Later, issues could occur
during development or after launch – maybe even years
after the launch. These issues could be the presence of
glass particles due to delamination or a shift in pH because
of elevated leachables. From a patient safety perspective,
this is disastrous, with a threat of blocked blood vessels,
adverse reactions, or unavailability due to market recall
respectively drug shortage.
